Triple Combination Therapy With Vedolizumab, Adalimumab, And Methotrexate In Patients With High-Risk Crohn'S Disease: Interim Analysis From The Open-Label, Phase 4 Explorer Trial
Adalimumab;Methotrexate;Vedolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Triple Combination Therapy With Vedolizumab, Adalimumab, And Methotrexate In Patients With High-Risk Crohn'S Disease: Interim Analysis From The Open-Label, Phase 4 Explorer Trial ### Output: Adalimumab;Methotrexate;Vedolizumab